Morning Briefing
Summaries of health policy coverage from major news organizations
Scientists At Retrovirus Conference Present Findings on Microbicide Gel, Truvada, Male Circumcision, ART Care By Nurses
At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports. With previous trials showing the gel reduced HIV vaginal infection risk, "[r]esearchers have wanted to know whether the gel could protect against anal transmission of the virus, since the risk of infection from unprotected anal sex may be more than 20 times that of unprotected vaginal sex," according to the blog (Melnick, 2/28).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
